[
    [
        {
            "time": "",
            "original_text": "国内医药界的“卖水人”正处十年黄金期，未来仍有8-12倍收入提升空间！",
            "features": {
                "keywords": [
                    "医药界",
                    "卖水人",
                    "十年黄金期",
                    "收入提升空间"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "国内医药界的“卖水人”正处十年黄金期，未来仍有8-12倍收入提升空间！",
                "Correlation": 6,
                "Sentiment": 9,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "凯莱英（002821）2021年一季报点评：业绩基本符合我们预期，汇率及股权激励费用影响表观增速！【东吴医药朱国广团队】",
            "features": {
                "keywords": [
                    "凯莱英",
                    "2021年一季报",
                    "业绩预期",
                    "汇率",
                    "股权激励费用",
                    "表观增速"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "凯莱英（002821）2021年一季报点评：业绩基本符合我们预期，汇率及股权激励费用影响表观增速！【东吴医药朱国广团队】",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        }
    ]
]